$0.14
-3.29%
N/A-$0.00
헬스케어
의료 - 유통
NASDAQ
활발히 거래 중
Cellyan Biotechnology Co., Ltd는 투자 지주 회사로서 주로 일반의약품(OTC) 분야에서 활동하며 홍콩과 중국 본토 시장에 서비스를 제공합니다. 이 회사의 서비스는 OTC 의약품의 ...
Cellyan Biotechnology Co., Ltd는 투자 지주 회사로서 주로 일반의약품(OTC) 분야에서 활동하며 홍콩과 중국 본토 시장에 서비스를 제공합니다. 이 회사의 서비스는 OTC 의약품의 ...
Operated through the subsidiary Joint Cross Border, this service provides essential logistical support for the OTC pharmaceutical e-commerce sector. It covers customs clearance, specialized drug registration, warehousing facilities, and supply chain management to facilitate the movement of pharmaceutical goods across borders into Mainland China.
가격대: N/A - Service-based contract pricing
페인 포인트: Complex cross-border customs regulations, difficulty in drug registration, inefficient warehousing in new markets, and fragmented supply chain visibility.
솔루션: Turnkey solutions for customs clearance, professional drug registration, end-to-end warehousing, and streamlined e-commerce distribution.
대상 사용자: Pharmaceutical manufacturers, e-commerce platform merchants, and international pharmaceutical distributors targeting the Hong Kong and Mainland China markets.
Operated through the subsidiary V-Alliance, this service focuses on the sourcing, procurement, and distribution of a wide range of OTC pharmaceutical products. The portfolio includes traditional Chinese medicines manufactured in Hong Kong and other regions, as well as various non-Chinese healthcare products.
가격대: N/A - Wholesale and distribution pricing
페인 포인트: High barrier to entry for sourcing diverse OTC products, fragmented distribution channels, and difficulties in scaling reach to retail pharmacies.
솔루션: Centralized sourcing capabilities, efficient wholesale distribution channels, and increased market reach for pharmaceutical suppliers.
대상 사용자: Retail pharmacies, healthcare merchants, and regional pharmaceutical distributors.